期刊文献+

丙种球蛋白辅助治疗小儿川崎病的疗效观察 被引量:10

Clinical Observation of Infantile Kawasaki Disease Treated by Gammaglobulin Adjunctive Therapy
下载PDF
导出
摘要 目的:探讨不同剂量丙种球蛋白治疗小儿川崎病的临床疗效。方法:选取我院2006年7月~2009年8月收治的120例川崎病患儿的临床资料,随机分为A、B、C三组,每组40例,三组患者均采用静脉注射丙种球蛋白进行治疗,A组静脉滴注丙种球蛋白2g/kg;B组静脉滴注丙种球蛋白1g/kg×2d;C组静脉滴注丙种球蛋白0.4g/(kg·d)×5d,各组其他治疗相同。观测患儿退热、淋巴结肿大、粘膜充血消退、多形性皮疹及手足症状消退的时间及冠状动脉损害发生率(CAL),并进行统计学分析。结果:A组退热、淋巴结肿大、粘膜充血消退、多形性皮疹及手足症状消退时间较B、C组短,且差异有统计学意义(P<0.05)。B组与C组无明显差异(P>0.05),A、B、C各组CAL无显著性差异(P>0.05),三组均未见明显不良反应。结论:静脉丙种球蛋白2g/kg,单次给药治疗川崎病,能更好的退热,并有效预防冠状动脉并发症的发生,疗效满意值得在临床推广。 Objective: To investigate the dose immunoglobulin in clinical treatment of children with Kawasaki disease.Methods: The hospital in July 2006 - August 2009 120 patients admitted to the clinical data of children with Kawasaki disease were randomly divided into A, B, C three groups, each group 40 cases, three groups of patients were treated with intravenous globulin treatment, A group of intravenous gamma globulin 2g/kg; B group of intravenous gamma globulin lg/kg×2d; C group of intravenous gamma globulin 0.4g / (kg.d) × 5d,the same as other treatment groups. Observed in children with fever, swollen lymph nodes, mucosa congestion subsided and polymorphous skin rash and hand-foot time and remission rate of coronary artery lesions (CAL), and analyzed statistically.Results: A group of fever, swollen lymph nodes, mucosa congestion subsided and polymorphous skin rash and remission time than hand-foot B, C was shorter, and the difference was statistically significant (P 〈0.05). B group and C group no significant difference (P〉 0.05), A, B, C CAL in each group no significant difference (P〉 0.05), three groups were no obvious adverse reactions.Conclusion: Intravenous gamma globulin 2g/kg, single dose treatment of Kawasaki disease, better cooling, and prev.ent the occurrence of coronary complications, results were satisfactory in clinical promotion.
作者 胡淑华
出处 《中国医药导刊》 2011年第4期619-620,共2页 Chinese Journal of Medicinal Guide
关键词 川崎病 丙种球蛋白 不同剂量 临床疗效 Kawasaki disease Gamma globulin Different doses Clinical efficacy
  • 相关文献

参考文献4

二级参考文献17

  • 1杜忠东,梁璐,孟晓萍,李棠,张拓红,川崎富作,柳川洋,北京小儿川崎病流行病学调查协作组.1995~1999年北京住院小儿川崎病流行病学调查[J].中华医学杂志,2003,83(21):1874-1878. 被引量:25
  • 2梁翊常,王乃坤,赵欣军.1987~1991年78所医院川崎病住院患儿发病调查[J].临床儿科杂志,1994,12(5):319-320. 被引量:30
  • 3金兰中,李国敏,马桂琴,朱家莱.川崎病的超声心动图检查[J].中华心血管病杂志,1996,24(1):38-40. 被引量:26
  • 4胡亚美 江载芳.诸福棠实用儿科学[M](第7版)[M].北京:人民卫生出版社,2002.1199-1201.
  • 5易岂建 杨锡强 等.川崎病患者淋巴细胞P53基因的检测及临床意义[J].中华微生物学和免疫学杂志,1999,19:258-258.
  • 6Newburger JW, Takahashi M, Beiser AS, et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki Syndrome[J]. N Engl J Med, 1991,324:1633-1639.
  • 7Shulman ST. Kawasaki disease and IVIG: What's going on here? Immunotherapy with intravenous immunoglobulings[M]. edited by Imbach P, Academic Press, San Diego, 1991,261-268.
  • 8Jason J, Gregg L, Han A, et al. Immunoregulatory change in Kawasaki disease [ J ]. Clin Immunol Immunopathol,1997,84: 296-303.
  • 9Fujieda M, Oishi N, Kurashige T. Antibodies to endothelial cells in Kawasaki disease [J ]. Clin Exp Immunol, 1997,107:120-126.
  • 10柳川洋,中村好一,屋代真弓,等编集.川崎病の疫学-30年间の總括.东京:诊断と巴西治疗社,2002.93—96.

共引文献180

同被引文献57

  • 1应国清,俞志明,单剑峰,易喻.北五味子有效组分的研究进展[J].河南中医,2005,25(6):84-87. 被引量:104
  • 2陈茂荣,杨运刚.甲基泼尼松龙治疗川崎病的疗效及对冠状动脉影响的探讨[J].临床儿科杂志,2006,24(6):520-522. 被引量:7
  • 3胡亚美 江载芳.诸福棠实用儿科学[M]第7版[M].北京:人民卫生出版社,2002.1514.
  • 4何兵,杨锦艳,李小欧,等.丙种球蛋白无反应型川崎病小儿临床特征分析[J].中国导刊.2013.48(1):33-36.
  • 5Onouchi Y,Ozaki K,Burns JC. A genome-wide association study identifies three new risk loci for Kawasaki disease[J].Nature genetics,2012,(05):517-521.
  • 6Kim JJ,Hong YM,Sohn S. A genome-wide association analysis reveals 1p31 and 2p13.3 as susceptibility loci for Kawasaki disease[J].Human Genetics,2011,(05):487-495.
  • 7Kim H J,Choi E H,Kil H R.Association between adipokines and coronary artery lesions in children with Kawasaki Disease[J].J Korean Med Sci,2014,29(10):1385-1390.
  • 8Tissandier C,Lang M,Lusson J R,et al.Kawasaki shock syndrome complicating a recurrence of Kawasaki disease[J].Pediatrics,2014,134(6):1695-1699.
  • 9Goto M,Miyagawa N,Kikunaga K,et al.High incidence of adrenal suppression in children with Kawasaki disease treated with intravenous immunoglobulin plus prednisolone[J].Endocr J,2015,62(2):145-151.
  • 10Sengupta D,Kahn AM,Burns JC,et al.Image-based modeling of hemodynamics in coronary artery aneurysms caused by Kawasaki disease[J].Biomechanics and modeling in mechanobiology,2012,11(6):915-932.

引证文献10

二级引证文献67

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部